Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Aug;31(8):4942-4943.
doi: 10.1245/s10434-024-15172-5. Epub 2024 Mar 12.

ASO Author Reflections: Adjuvant Chemoradiation in Resected Biliary Cancers-Insights and Implications

Dana A Dominguez  1 , Laleh G Melstrom  2
Affiliations

ASO Author Reflections: Adjuvant Chemoradiation in Resected Biliary Cancers-Insights and Implications

Dana A Dominguez et al. Ann Surg Oncol. 2024 Aug.
No abstract available

PubMed Disclaimer

References

    1. Ben-Josef E, Guthrie KA, El-Khoueiry AB, Corless CL, Zalupski MM, Lowy AM, et al. SWOG S0809: a phase II intergroup trial of adjuvant capecitabine and gemcitabine followed by radiotherapy and concurrent capecitabine in extrahepatic cholangiocarcinoma and gallbladder carcinoma. J Clin Oncol. 2015;33:2617–2622. doi: 10.1200/JCO.2014.60.2219. - DOI - PMC - PubMed
    1. Dominguez D, Wong P, Chen YJ, et al. Adjuvant chemoradiation in resected biliary adenocarcinoma: evaluation of SWOG S0809 with a large national database. Ann Surg Oncol. 2024 doi: 10.1245/s10434-024-15117-y. - DOI - PMC - PubMed
    1. Stein A, Arnold D, Bridgewater J, Goldstein D, Jensen LH, Klümpen HJ, et al. Adjuvant chemotherapy with gemcitabine and cisplatin compared to observation after curative intent resection of cholangiocarcinoma and muscle invasive gallbladder carcinoma (ACTICCA-1 trial): a randomized, multidisciplinary, multinational phase III trial. BMC Cancer. 2015;15. doi:10.1186/S12885-015-1498-0. - PMC - PubMed
    1. Oh DY, Ruth He A, Qin S, Chen LT, Okusaka T, Vogel A, et al. Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer. NEJM Evidence. 2022;1. doi:10.1056/EVIDoa2200015. - PubMed

MeSH terms